Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosisHannes Vietzen, Elisabeth Puchhammer‐Stöckl, S. Berger et al.|Cell|2023Cited by 170
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A. Mayer, Georg A. Böhmig, Eva Schrezenmeier et al.|New England Journal of Medicine|2024Cited by 151
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19Hannes Vietzen, Elisabeth Puchhammer‐Stöckl, Alexander Zoufaly et al.|Genetics in Medicine|2021Cited by 138
HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLDHannes Vietzen, Elisabeth Puchhammer‐Stöckl, Philippe L. Furlano et al.|Blood|2022Cited by 44
NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung TransplantationHannes Vietzen, Elisabeth Puchhammer‐Stöckl, Karin Pollak et al.|The Journal of Infectious Diseases|2017Cited by 32